Stewart Brian D, Kaye Frederic, Machuca Tiago, Mehta Hiren J, Mohammed Tan-Lucien, Newsom Kimberly J, Starostik Petr
University of Florida, Gainesville, FL, USA.
Int J Surg Pathol. 2020 Feb;28(1):102-108. doi: 10.1177/1066896919865944. Epub 2019 Aug 5.
SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity with a poor prognosis that is defined by certain genetic alterations in the BAF chromatin remodeling complex, specifically and . We present a case of a SMARCA4-DTS in a 59 year-old male with a heavy smoking history who was found to have an unexpected right upper lobe lung mass on routine chest radiograph after a visit to his primary care physician. This led to a biopsy with a diagnosis of poorly differentiated carcinoma at an outside institution. The patient was subsequently seen at our facility for surgical intervention. The right upper lobectomy contained a 7.2-cm poorly differentiated malignancy with slightly discohesive cells arranged in sheets and nests, abundant geographic necrosis, and with many areas showing rhabdoid morphology. The tumor was focally reactive for CK7, AE1/3, Cam5.2, and SALL4 and showed scattered reactivity for CD34 and SOX2. There was complete loss of reactivity for both SMARCA4 and SMARCA2. The histology and immunophenotype were all consistent with the diagnosis of a SMARCA4-DTS. Next-generation sequencing showed a frameshift mutation in the gene and no abnormality with the gene. Interestingly, this tumor was confined to the pulmonary parenchyma with no invasion of the visceral pleura nor the mediastinum and with no clinically apparent metastases at the time of presentation. This case is presented to add to the cohort of cases described to date and to discuss the immunohistochemical and molecular findings with regard to .
SMARCA4缺陷型胸肉瘤(SMARCA4-DTS)是一种最近被描述的预后不良的实体瘤,由BAF染色质重塑复合体中的某些基因改变所定义,具体为 和 。我们报告一例59岁有重度吸烟史的男性SMARCA4-DTS病例,该患者在就诊于初级保健医生后,常规胸部X线检查发现右上叶肺部有意外肿块。这导致在外院进行活检,诊断为低分化癌。患者随后到我们机构接受手术干预。右上叶切除标本中含有一个7.2厘米的低分化恶性肿瘤,细胞轻度松散,呈片状和巢状排列,有大量地图状坏死,许多区域显示横纹肌样形态。肿瘤对CK7、AE1/3、Cam5.2和SALL4呈局灶性反应,对CD34和SOX2呈散在反应。SMARCA4和SMARCA2均完全丧失反应性。组织学和免疫表型均符合SMARCA4-DTS的诊断。二代测序显示 基因存在移码突变, 基因无异常。有趣的是,该肿瘤局限于肺实质,未侵犯脏层胸膜和纵隔,就诊时无临床明显转移。本文报告此病例以增加迄今所描述的病例队列,并讨论关于 的免疫组化和分子学发现。